The Meaning of a Title: Global & Regional Health Technology Assessment

Most read articles by the same author(s)

• Massimo Allegri, Carlo Lucioni, Silvio Mazzi, Giulio Serra, Social cost of chronic pain in Italy , Global and Regional Health Technology Assessment: Vol. 2 No. 1 (2015): January-April 2015
• Carlo Lucioni, Sergio Iannazzo, Silvio Mazzi, Giorgia Saporiti, Silvia Chiroli, Cost-effectiveness of ponatinib in chronic myeloid leukemia in Italy , Global and Regional Health Technology Assessment: Vol. 2 No. 1 (2015): January-April 2015
• Nicoletta Martone, Carlo Lucioni, Silvio Mazzi, Valeria Fadda, New Oncological Drugs: Analysis of Survival Gain , Global and Regional Health Technology Assessment: Vol. 1 No. 1 (2014): January-June 2014
• Carlo Lucioni, Claudio Jommi, Value of health technologies, HTA and decisions , Global and Regional Health Technology Assessment: Vol. 4 No. 1 (2017): January-December 2017
• Nicoletta Martone, Carlo Lucioni, Silvio Mazzi, Valeria Fadda, Cost-Effectiveness Evaluation of Oncological Drugs Newly Marketed in Italy , Global and Regional Health Technology Assessment: Vol. 1 No. 2 (2014): July-December 2014
• Roberto Gasparini, Daniela Amicizia, Piero Luigi Lai, Carlo Lucioni, Donatella Panatto, Health Technology Assessment and vaccinations in Italy , Global and Regional Health Technology Assessment: Vol. 1 No. 1 (2014): January-June 2014
• Carlo Lucioni, Silvio Mazzi, Elisa Rossi, Rita Rielli, Silvia Calabria, Aldo Pietro Maggioni, Therapeutic Strategies and Health Costs of Patients Admitted for a Cardiovascular Event in Italy , Global and Regional Health Technology Assessment: Vol. 3 No. 2 (2016): May-August 2016
• Clement Tournier, Valerie Deroo, Sara Villa, Giovanni Giuliani, Carlo Lucioni, Silvio Mazzi, Roberto Ravasio, An Approach to Evaluate Payment-by-Results Agreements , Global and Regional Health Technology Assessment: Vol. 3 No. 2 (2016): May-August 2016
• Carlo Lucioni, Silvio Mazzi, Roberto Caporali, Budget impact analysis of infliximab biosimilar: the Italian scenery , Global and Regional Health Technology Assessment: Vol. 2 No. 2 (2015): May-August 2015